ReviewJournal of experimental & clinical cancer research : CR2021

Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.

Fengzhi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.